Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size

Review of Prescription Drug User Fees

The Prescription Drug User Fee Act of 1992, Pub. L. 102-571, authorized Food and Drug Administration to collect fees from pharmaceutical and biotechnology companies seeking Food and Drug Administration approval of certain human drug and biological products to expedite the review of human drug applications. Food and Drug Administration is expected to use the user fees it collects under the Act to meet its goals for the timely review of human drug applications. We will review Food and Drug Administration policies and procedures and financial records related to prescription drug user fees to determine whether Food and Drug Administration appropriately expended user-fee collections and accurately computed user-fee rates.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
October 2017 Food and Drug Administration Review of Prescription Drug User Fees Office of Audit Services W-00-16-50003 2018

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201